Table 2.
IC50 of Bz and 1g on epimastigotes (Epi), trypomastigotes (Tryp) amastigotes (Ama), Vero cells and Cardiomyocytes (Vero/CM) incubated in medium with and without hemin. Results represent the mean and standard deviation of at least three experiments in duplicate.
Medium | 1g |
Bz |
||||||
---|---|---|---|---|---|---|---|---|
Epia | Trypb | Amac | Vero/CMd | Epia | Trypb | Amac | Vero/CMd | |
Without heme | 19.5 ± 2.5 | >100 | 12.2 ± 2.6 | >100 | 2.9 ± 0.6 | 13 ± 5.7 | 3.25 ± 0.3 | >100 |
With heme* | <1** | 11.7 ± 4** | 6.3 ± 2.5** | >100 | 9.5 ± 5.2** | 12 ± 6.5 | 2.5 ± 1.4 | >100 |
*30 μM of heme diluted in BHI, RPMI and DMEM medium.
**Statistically significant p < 0.05 using one-way ANOVA.
IC50 (Concentration that inhibits the growth of 50% of T. cruzi Y epimastigote forms within 72 h). Viability was measure counting motile parasites in Neubauer chamber.
IC50 (Concentration that kills 50% of T. cruzi Y trypomastigotes within 24 h). Viability was measure using resazurin.
IC50 (Concentration that inhibits 50% of T. cruzi Y amastigotes after 72 h of treatment). Measured by counting the number of parasites stained with GIEMSA.
CC50 (Concentration that inhibits 50% of host cell growth after 72 h of treatment). Viability was measure using resazurin.